The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.

The Gram-negative bacterium Campylobacter jejuni is a major cause of foodborne disease in humans. After infection, C. jejuni rapidly colonizes the mucus layer of the small and large intestine and induces a potent pro-inflammatory response characterized by the production of a large repertoire of cyto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jiannan Cui, Coco Duizer, Lieneke I Bouwman, Kristel S van Rooijen, Carlos G P Voogdt, Jos P M van Putten, Marcel R de Zoete
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/fa8d0409b68d4f9eaf625093bfa3816b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa8d0409b68d4f9eaf625093bfa3816b
record_format dspace
spelling oai:doaj.org-article:fa8d0409b68d4f9eaf625093bfa3816b2021-12-02T20:00:26ZThe ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.1553-73661553-737410.1371/journal.ppat.1009787https://doaj.org/article/fa8d0409b68d4f9eaf625093bfa3816b2021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1009787https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374The Gram-negative bacterium Campylobacter jejuni is a major cause of foodborne disease in humans. After infection, C. jejuni rapidly colonizes the mucus layer of the small and large intestine and induces a potent pro-inflammatory response characterized by the production of a large repertoire of cytokines, chemokines, and innate effector molecules, resulting in (bloody) diarrhea. The virulence mechanisms by which C. jejuni causes this intestinal response are still largely unknown. Here we show that C. jejuni releases a potent pro-inflammatory compound into its environment, which activates an NF-κB-mediated pro-inflammatory response including the induction of CXCL8, CXCL2, TNFAIP2 and PTGS2. This response was dependent on a functional ALPK1 receptor and independent of Toll-like Receptor and Nod-like Receptor signaling. Chemical characterization, inactivation of the heptose-biosynthesis pathway by the deletion of the hldE gene and in vitro engineering identified the released factor as the LOS-intermediate ADP-heptose and/or related heptose phosphates. During C. jejuni infection of intestinal cells, the ALPK1-NF-κB axis was potently activated by released heptose metabolites without the need for a type III or type IV injection machinery. Our results classify ADP-heptose and/or related heptose phosphates as a major virulence factor of C. jejuni that may play an important role during Campylobacter infection in humans.Jiannan CuiCoco DuizerLieneke I BouwmanKristel S van RooijenCarlos G P VoogdtJos P M van PuttenMarcel R de ZoetePublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 17, Iss 8, p e1009787 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Jiannan Cui
Coco Duizer
Lieneke I Bouwman
Kristel S van Rooijen
Carlos G P Voogdt
Jos P M van Putten
Marcel R de Zoete
The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
description The Gram-negative bacterium Campylobacter jejuni is a major cause of foodborne disease in humans. After infection, C. jejuni rapidly colonizes the mucus layer of the small and large intestine and induces a potent pro-inflammatory response characterized by the production of a large repertoire of cytokines, chemokines, and innate effector molecules, resulting in (bloody) diarrhea. The virulence mechanisms by which C. jejuni causes this intestinal response are still largely unknown. Here we show that C. jejuni releases a potent pro-inflammatory compound into its environment, which activates an NF-κB-mediated pro-inflammatory response including the induction of CXCL8, CXCL2, TNFAIP2 and PTGS2. This response was dependent on a functional ALPK1 receptor and independent of Toll-like Receptor and Nod-like Receptor signaling. Chemical characterization, inactivation of the heptose-biosynthesis pathway by the deletion of the hldE gene and in vitro engineering identified the released factor as the LOS-intermediate ADP-heptose and/or related heptose phosphates. During C. jejuni infection of intestinal cells, the ALPK1-NF-κB axis was potently activated by released heptose metabolites without the need for a type III or type IV injection machinery. Our results classify ADP-heptose and/or related heptose phosphates as a major virulence factor of C. jejuni that may play an important role during Campylobacter infection in humans.
format article
author Jiannan Cui
Coco Duizer
Lieneke I Bouwman
Kristel S van Rooijen
Carlos G P Voogdt
Jos P M van Putten
Marcel R de Zoete
author_facet Jiannan Cui
Coco Duizer
Lieneke I Bouwman
Kristel S van Rooijen
Carlos G P Voogdt
Jos P M van Putten
Marcel R de Zoete
author_sort Jiannan Cui
title The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
title_short The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
title_full The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
title_fullStr The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
title_full_unstemmed The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
title_sort alpk1 pathway drives the inflammatory response to campylobacter jejuni in human intestinal epithelial cells.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/fa8d0409b68d4f9eaf625093bfa3816b
work_keys_str_mv AT jiannancui thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT cocoduizer thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT lienekeibouwman thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT kristelsvanrooijen thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT carlosgpvoogdt thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT jospmvanputten thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT marcelrdezoete thealpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT jiannancui alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT cocoduizer alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT lienekeibouwman alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT kristelsvanrooijen alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT carlosgpvoogdt alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT jospmvanputten alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
AT marcelrdezoete alpk1pathwaydrivestheinflammatoryresponsetocampylobacterjejuniinhumanintestinalepithelialcells
_version_ 1718375758813986816